Dr. Sang-Moo Kang, professor in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.7 million federal grant to study seasonal
Read more
Home »
Researchers in the United States and Austria have demonstrated the potential of a modified influenza virus as a vaccine to protect against viral respiratory pathogens,
Read more
The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease and Emergence Research (CIDER). The
Read more
The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the causative pathogen of coronavirus disease 2019 (COVID-19) – has already claimed more
Read more
Wide-scale vaccine distribution is now taking place in the more economically developed countries worldwide, with counties such as the USA and UK having now vaccinated
Read more
Analysis indicated the number of mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain (RBD) doubles every 72 days. As the coronavirus
Read more
Aspirin is an established, safe, and low-cost medication in long-standing common use in prevention and treatment of cardiovascular diseases, and in the past a pain
Read more
(Reuters) – Abbott Laboratories said on Friday that the U.S. Food and Drug Administration granted emergency use authorization for its molecular test to detect and
Read more
Researchers found a small molecule that inhibits different virus proteins and significantly reduces infection in cells. Combined with the antiviral remdesivir, its potency increases significantly,
Read more
Beating back Covid right now comes down to balancing supply and demand. With hopes pinned to vaccines, demand has far outstripped the supply of doses.
Read more